About Us
ANAS Indigenous is one of the leaders in pharmaceutical research, operated by scientific advances. Our mission is to produce superior pharmaceuticals that improve patient care around the world. We seek out revolutionary medicines that address unresolved medical difficulties by pushing scientific boundaries and setting new standards in healthcare. Committed to superiority, integrity, and transparency, we maintain the highest standards, moving medical research forward and bringing in a wave of positive transformation for everybody.
Our Mission
Our primary goal is the well-being of our patients, as we strive to improve their quality of life and inspire hope for better days ahead. We are committed to expanding worldwide access to our medicines while focusing on affordability and reach.
Our Vision
We aspire to cure critical diseases worldwide. We are driven by innovation and the search for affordable, effective medicines. We envision a healthy world where everyone has access to care.
Unleashing the
Future of Healthcare
At ANAS Indigenous, our mission is not just about creating medicines, it's about
crafting healthier tomorrows. We create innovative medicines that promote health and
wellness by targeting serious diseases and investing in rigorous research and
development. Our commitment is to make these treatments accessible to patients,
regardless of location or income.
Our Guiding Principles
Competence at Hand
- Have a strong scientific team.
- Capable of leading infectious disease and health improvements.
R&D commitment
- An exceptional group of scientists and researchers who work continuously.
- Believe that our R&D efforts save and improve the lives of countless people.
Innovative Concepts
- Always keep an eye out for innovative drug development opportunities.
- Dedicated to implementing cutting-edge technologies.
Collaborative Approach
- Teamwork is the foundation of our methodology.
- Interaction with patients, medical experts, and other stakeholders regularly.
Our Distinctive Quality
Our product selection is designed to fulfil the needs of people suffering from chronic diseases which require long-term therapy. Our medicines are intended to efficiently treat a wide range of chronic disorders, from diabetes and heart disease to infectious diseases and asthma. In addition, we provide a comprehensive choice of drugs in Gynaecology, Paediatrics, Orthopaedics, Dermatology, and general healthcare.
Our Distinctive
Quality
Our product selection is designed to fulfil the needs of people suffering from chronic diseases which require long-term therapy. Our medicines are intended to efficiently treat a wide range of chronic disorders, from diabetes and heart disease to infectious diseases and asthma. In addition, we provide a comprehensive choice of drugs in Gynaecology, Paediatrics, Orthopaedics, Dermatology, and general healthcare.
Pioneering Wellness across Various Health Arenas
Chronic Condition
Our treatments for chronic conditions like diabetes, heart disease, and asthma provide essential support for long-term patient care.
Healthcare Professional
We provide high-quality, innovative drugs that healthcare professionals trust and rely upon for patient care.
Elderly Patients
Our medicines help manage age-related conditions, ensuring healthier, more vibrant lives for our elderly patients.
Children
and Adolescents
We aim to nurture the future, offering treatments and preventives for childhood illnesses and supporting healthy growth.
Athletes and Fitness Enthusiasts
Our range of pain relievers and anti-inflammatory drugs supports active lifestyles and swift recovery from sports injuries.
Women's
Health
With an understanding of women's unique health needs, we offer a range of products, from contraception to calcium supplements, promoting overall well-being.
Our Board Of Directors
Dr. Anup Kumar Gupta, PhD
(Co-Founder & MD)
Dr Gupta has an extensive experience of more than 30 years in the field of professional education . He was instrumental in establishing many educational Institutions and has been a board member of various universities and schools . Presently he is a Pro-Vice-Chancellor of GLA Universiry , Mathura A+ grade university by NAAC . His academic achievements include a Gold Medal in MA and MPhil and PhD in English Literature, Executive MBA from IIT Bombay and Postgraduation from MIchigan State University , USA
Shweta Kushwaha
(Co-Founder & CFO)
Shweta Kushwaha is the Co Founder and serve as Chief Financial Officer at ANAS Indigenous Private Limited, a seasoned research professional with 8.5 years of expertise in the field of tuberculosis. Her extensive background includes Microbiology, Proteomics, Bioinformatics, and Molecular Biology. Shweta has dedicated her career to advancing our understanding of tuberculosis, particularly focusing on challenging aspects like Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) cases. Her contributions extend beyond research, as she plays an instrumental role in shaping the financial aspects of our organization. Shweta's commitment to excellence, coupled with her strong work ethics, positions her as an indispensable leader within our board of directors. Her leadership not only significantly contributes to our ongoing success but also aligns seamlessly with the overarching mission of ANAS Indigenous.
M Nava Bharath
(Founder & CEO)
As the Founder and Chief Executive Officer at ANAS Indigenous Private Limited, Nava Bharath brings a wealth of experience and dedication to the forefront of tuberculosis research. With an impressive 5 years of expertise in phytopharmacology, microbiology, and cell biology including mammalian cell culture and molecular techniques, and also carried out In-vitro and In-vivo studies using various cellular and molecular techniques. Navabharath has been a pivotal force in advancing our understanding of paratuberculosis and tuberculosis, with a specific focus on Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) cases. Notably, Navabharath holds two patents stemming from his groundbreaking research. His commitment to innovation and excellence in the field is evident, and he plays a crucial role in driving our organization's mission forward. Nava Bharath's leadership, dedication, and pioneering spirit make him an essential member of our board of directors at ANAS Indigenous.
Tuberculosis Research Activities at Anas
Our commitment to TB reduction at ANAS Indigenous goes beyond traditional measures, concentrating on unique treatment options. We are pleased to announce revolutionary activities aimed at making TB therapy available to Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) patients while minimising side effects and assuring cost-effectiveness.
Our objective is to transform TB treatment, particularly in the context of MDR and XDR TB. We are motivated to deliver inexpensive solutions, eliminate side effects, and pursue cutting-edge research avenues, all with the ultimate objective of eliminating Tuberculosis from the world.
Cost-effective therapy for MDR and XDR TB
Decreasing Side Effects
Phytopharmaceutical Innovations
Global Engagement
Low-Range Medications
Frequently Asked Questions
ANAS specializes in targeting serious medical conditions, including tuberculosis, heart disease, diabetes, and gastrointestinal issues. Additionally, we are dedicated to addressing public health emergencies in areas such as Gynecology, Pediatrics, Orthopedics, Dermatology, and general healthcare. Our proactive approach enables us to develop innovative solutions that positively impact patients' lives and contribute to a healthier society.
ANAS distinguishes itself from other pharmaceutical companies by focusing on indigenous drug development, offering effective and low-cost medications with minimal side effects. Our dedication to patient-centric approaches, affordability, and ethical practices makes us a trusted partner in improving healthcare outcomes.
At ANAS Pharmaceuticals, we are dedicated to improving healthcare outcomes for all by providing personalized treatments that cater to diverse patient profiles. Our dedication to developing treatments for chronic conditions, elderly patients, children, adolescents, athletes, women, and our unwavering commitment to developing effective and targeted therapies sets us apart, ensuring that every individual receives the care they deserve.
ANAS Pharmaceuticals, where our vision is to lead in resolving global health challenges through innovative medications and advanced research tools. With a patient-centric approach, we pioneer cutting-edge treatments that push medical boundaries. We strive for a global impact by making our medications accessible and bridging healthcare gaps. Through partnerships, ethical practices, and sustainable operations, we aim to revolutionize healthcare and create a brighter future for all.
